Radioimmunotherapy in colorectal cancer treatment: present and future
Colorectal cancer (CRC) is a deadly form of cancer worldwide. Patients with locally advanced rectal cancer and metastatic CRC have a poor long-term prognosis, and rational and effective treatment remains a major challenge. Common treatments include multi-modal combinations of surgery, radiotherapy,...
Main Authors: | Jingyi Shi, Zhuang Sun, Zhaoya Gao, Dandan Huang, Haopeng Hong, Jin Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1105180/full |
Similar Items
-
Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
by: An Huang, et al.
Published: (2023-04-01) -
Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China
by: An Huang, et al.
Published: (2024-02-01) -
From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?
by: Shiya Yao, et al.
Published: (2023-09-01) -
Bibliometric analysis of preoperative radiotherapy for locally advanced rectal cancer: evolution and future
by: Zhen-Hong Weng, et al.
Published: (2025-02-01) -
Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer
by: An Huang, et al.
Published: (2024-06-01)